Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)
China flag China · Delayed Price · Currency is CNY
9.15
-0.05 (-0.54%)
May 20, 2026, 11:30 AM CST

SHA:600420 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,7244,0066,2125,9736,1484,284
Short-Term Investments
-3,0551,431---
Cash & Short-Term Investments
3,7247,0617,6435,9736,1484,284
Cash Growth
-27.11%-7.61%27.97%-2.86%43.51%15.18%
Accounts Receivable
1,7871,1671,3612,0512,6563,048
Other Receivables
85.9181.5585.5584.0792.8596.91
Receivables
1,8731,2481,4472,1352,7483,144
Inventory
1,8491,7492,2092,2802,4403,072
Prepaid Expenses
-71.0770.2961.6347.6940.21
Other Current Assets
3,9671,123315.43207.49300.4345.15
Total Current Assets
11,41311,25311,68410,65711,68410,886
Property, Plant & Equipment
5,2435,3415,5505,8856,2466,511
Long-Term Investments
422.281,2331,3161,431376.22370.77
Goodwill
160.15160.15160.15160.15160.15160.15
Other Intangible Assets
744.39759.99591.29511.18517.08549.09
Long-Term Deferred Tax Assets
104.93115.82103.15153.13239.09188.75
Long-Term Deferred Charges
249.34227.36333.66331.74227.83144.74
Other Long-Term Assets
1,122136.21216.67223.65179.17259.22
Total Assets
19,46019,22719,95619,35219,63019,070
Accounts Payable
1,8941,6481,1031,3741,2491,542
Accrued Expenses
144.53935.671,4201,5951,6751,670
Short-Term Debt
--50.0545.05321.142,014
Current Portion of Long-Term Debt
--1,031-48.37539.63
Current Portion of Leases
98.858.8610.69.8640.13
Current Income Taxes Payable
78.3444.2572.5129.9537.9430.86
Current Unearned Revenue
132.1693.81193.33244.6344.17201.23
Other Current Liabilities
918.71403.65465.17480.59509.97804.25
Total Current Liabilities
3,1773,1344,3443,7804,1966,843
Long-Term Debt
---1,0312,9551,547
Long-Term Leases
28.8533.7547.9457.9768.5743
Long-Term Unearned Revenue
86.3283.49113.99122.8138.01140.33
Pension & Post-Retirement Benefits
11.4111.410.360.520.570.84
Long-Term Deferred Tax Liabilities
62.5762.570.7722.15119.55126.19
Other Long-Term Liabilities
56.9656.9656.96---
Total Liabilities
3,4233,3824,6345,0147,4788,700
Common Stock
1,3411,3411,3411,3411,1721,027
Additional Paid-In Capital
5,2135,2135,2045,2043,5872,545
Retained Earnings
7,3647,2266,6605,8455,2874,762
Comprehensive Income & Other
-1.11-1.11-0.91-1.09259.34258.88
Total Common Equity
13,91713,77913,20412,38810,3058,593
Minority Interest
2,1202,0662,1181,9501,8471,777
Shareholders' Equity
16,03715,84515,32214,33812,15310,370
Total Liabilities & Equity
19,46019,22719,95619,35219,63019,070
Total Debt
37.8642.61,1381,1453,4034,184
Net Cash (Debt)
3,6867,0186,5054,8282,74599.84
Net Cash Growth
-26.27%7.89%34.74%75.89%2649.36%-
Net Cash Per Share
2.755.234.853.792.370.08
Filing Date Shares Outstanding
1,3411,3411,3411,3411,1721,027
Total Common Shares Outstanding
1,3411,3411,3411,3411,1721,027
Working Capital
8,2378,1197,3406,8777,4894,044
Book Value Per Share
10.3810.279.859.248.578.11
Tangible Book Value
13,01312,85912,45211,7179,6287,884
Tangible Book Value Per Share
9.709.599.288.747.997.42
Buildings
-4,3854,4914,4723,9453,874
Machinery
-8,5258,4538,3708,1847,920
Construction In Progress
-208.91142.68101.35642.37585.52
Source: S&P Global Market Intelligence. Standard template. Financial Sources.